GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bio-Thera Solutions Ltd (SHSE:688177) » Definitions » Debt-to-Revenue

Bio-Thera Solutions (SHSE:688177) Debt-to-Revenue : 0.98 (As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Bio-Thera Solutions Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Bio-Thera Solutions's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ¥322.9 Mil. Bio-Thera Solutions's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ¥379.1 Mil. Bio-Thera Solutions's annualized Revenue for the quarter that ended in Sep. 2024 was ¥716.6 Mil. Bio-Thera Solutions's annualized Debt-to-Revenue for the quarter that ended in Sep. 2024 was 0.98.


Bio-Thera Solutions Debt-to-Revenue Historical Data

The historical data trend for Bio-Thera Solutions's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio-Thera Solutions Debt-to-Revenue Chart

Bio-Thera Solutions Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Revenue
Get a 7-Day Free Trial 145.14 0.03 0.04 0.02 0.69

Bio-Thera Solutions Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.78 0.50 0.92 0.71 0.98

Competitive Comparison of Bio-Thera Solutions's Debt-to-Revenue

For the Biotechnology subindustry, Bio-Thera Solutions's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bio-Thera Solutions's Debt-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bio-Thera Solutions's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Bio-Thera Solutions's Debt-to-Revenue falls into.



Bio-Thera Solutions Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Bio-Thera Solutions's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(158.787 + 323.835) / 704.795
=0.68

Bio-Thera Solutions's annualized Debt-to-Revenue for the quarter that ended in Sep. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(322.912 + 379.062) / 716.584
=0.98

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Sep. 2024) Revenue data.


Bio-Thera Solutions Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Bio-Thera Solutions's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Bio-Thera Solutions Business Description

Traded in Other Exchanges
N/A
Address
5th Floor, Building A6, 11 Kaiyuan Avenue, Guangzhou High-tech Industrial Development Zone, Science City, Guangdong Province, Guangzhou, CHN, 510530
Bio-Thera Solutions Ltd is engaged in research, development, and production of drugs and biosimilars. The company provides drug research and development; biotechnology consulting and communication services; services; medical research and experimental development; biological drug manufacturing; and pharmaceuticals retail.

Bio-Thera Solutions Headlines

No Headlines